GIPM
HCAT icon

G2 Investment Partners Management’s Health Catalyst HCAT Stock Holding History

G2 Investment Partners Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-93,518
Closed -$2.44M – 101
2020
Q1 		$2.44M Buy
+93,518
New +$2.86M 0.81% 40

Other funds holding HCAT

NVPX
Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

G2 Investment Partners Management's HCAT Position: Q2 2020 in Review

G2 Investment Partners Management sold out of Health Catalyst (HCAT) in Q2 2020, closing a stake of 93,518 shares — an estimated $2.44M sold.

G2 Investment Partners Management first reported a position in HCAT in Q1 2020 and held it in 1 quarter. The position peaked at $2.44M in Q1 2020. 128 funds tracked by Wall St. Rank hold HCAT as of Q2 2020.

  • G2 Investment Partners Management reported no remaining Health Catalyst position as of Q2 2020 after selling out during the quarter.
  • G2 Investment Partners Management sold 93,518 Health Catalyst shares in Q2 2020, an estimated $2.44M.
  • G2 Investment Partners Management first reported a position in Health Catalyst in Q1 2020 and held it in 1 quarter.
  • G2 Investment Partners Management's Health Catalyst position peaked at $2.44M in Q1 2020.
  • 128 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2020.

Based on G2 Investment Partners Management's 13F filing for Q2 2020, filed 14 Aug 2020.